REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 310 filers reported holding REPLIGEN CORP in Q1 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,048,651 | +15.7% | 69,484 | +2.9% | 0.01% | +11.1% |
Q2 2023 | $9,548,267 | +3031.6% | 67,498 | +3627.1% | 0.01% | – |
Q1 2023 | $304,900 | +0.2% | 1,811 | +0.7% | 0.00% | – |
Q4 2022 | $304,419 | -12.5% | 1,798 | -3.4% | 0.00% | – |
Q3 2022 | $348,000 | +30.3% | 1,862 | +13.1% | 0.00% | – |
Q2 2022 | $267,000 | -96.2% | 1,647 | -95.3% | 0.00% | -100.0% |
Q2 2021 | $6,961,000 | -8.3% | 35,172 | -10.6% | 0.01% | -14.3% |
Q1 2021 | $7,595,000 | +46.7% | 39,321 | +45.0% | 0.01% | +40.0% |
Q4 2020 | $5,177,000 | +52.4% | 27,124 | +17.3% | 0.01% | +25.0% |
Q3 2020 | $3,396,000 | +19.5% | 23,128 | +0.1% | 0.00% | 0.0% |
Q2 2020 | $2,843,000 | +17.4% | 23,108 | -7.8% | 0.00% | 0.0% |
Q1 2020 | $2,421,000 | -42.4% | 25,075 | -44.8% | 0.00% | -20.0% |
Q4 2019 | $4,200,000 | +20.6% | 45,400 | 0.0% | 0.01% | +25.0% |
Q3 2019 | $3,482,000 | -0.7% | 45,400 | +11.3% | 0.00% | 0.0% |
Q2 2019 | $3,507,000 | +137.4% | 40,800 | +63.2% | 0.00% | +100.0% |
Q1 2019 | $1,477,000 | – | 25,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |